Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Total Liabilities
Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) has total liabilities worth CN¥3.36 Billion CNY (≈ $491.24 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Anhui Huaheng Biotechnology Co. Ltd. A - Total Liabilities Trend (2012–2025)
This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Anhui Huaheng Biotechnology Co. Ltd. A's working capital to evaluate short-term liquidity relative to the company's equity base.
Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Anhui Huaheng Biotechnology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Niutech Environment Technology Corp
SHG:688309
|
China | CN¥189.23 Million |
|
Quanex Building Products
NYSE:NX
|
USA | $1.27 Billion |
|
Hextar Global Bhd
KLSE:5151
|
Malaysia | RM562.93 Million |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥1.52 Billion |
|
Beijing SL Pharmaceutical Co Ltd
SHE:002038
|
China | CN¥735.46 Million |
|
Risesun Real Estate Development Co Ltd
SHE:002146
|
China | CN¥120.08 Billion |
|
Jdd Tech New Mat Co Ltd
SHE:301538
|
China | CN¥243.00 Million |
|
Replimune Group Inc
NASDAQ:REPL
|
USA | $123.05 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Anhui Huaheng Biotechnology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688639 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anhui Huaheng Biotechnology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)
The table below shows the annual total liabilities of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥3.14 Billion ≈ $459.89 Million |
+29.28% |
| 2024-12-31 | CN¥2.43 Billion ≈ $355.74 Million |
+13.36% |
| 2023-12-31 | CN¥2.14 Billion ≈ $313.82 Million |
+293.18% |
| 2022-12-31 | CN¥545.44 Million ≈ $79.82 Million |
+87.45% |
| 2021-12-31 | CN¥290.98 Million ≈ $42.58 Million |
+14.96% |
| 2020-12-31 | CN¥253.11 Million ≈ $37.04 Million |
+31.55% |
| 2019-12-31 | CN¥192.41 Million ≈ $28.16 Million |
-16.65% |
| 2018-12-31 | CN¥230.84 Million ≈ $33.78 Million |
+14.65% |
| 2017-12-31 | CN¥201.33 Million ≈ $29.46 Million |
-4.03% |
| 2016-12-31 | CN¥209.78 Million ≈ $30.70 Million |
+20.06% |
| 2015-12-31 | CN¥174.73 Million ≈ $25.57 Million |
+28.66% |
| 2014-12-31 | CN¥135.81 Million ≈ $19.87 Million |
-17.45% |
| 2013-12-31 | CN¥164.52 Million ≈ $24.07 Million |
+39.31% |
| 2012-12-31 | CN¥118.10 Million ≈ $17.28 Million |
-- |
About Anhui Huaheng Biotechnology Co. Ltd. A
Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material mon… Read more